Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Mizuho Medy Co., Ltd. (4595:JPX), powered by AI.
Mizuho Medy Co., Ltd. is currently trading at ¥1,670. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Mizuho Medy Co., Ltd. on Alpha Lenz.
View Mizuho Medy Co., Ltd.'s valuation metrics on Alpha Lenz.
“Mizuho Medy Co., Ltd.'s ROE is 19.0%. Explore profitability and growth together.”
Ask for details →Mizuho Medy Co., Ltd. is a prominent entity in the healthcare and pharmaceutical industry, primarily focused on the development and distribution of medical equipment and diagnostic products. The company plays a vital role in supplying essential medical consumables and devices that cater to both domestic and international healthcare markets. Mizuho Medy's products are widely utilized in various medical settings, including hospitals, clinics, and laboratories, thereby supporting healthcare professionals in delivering critical patient care. As a player in the global healthcare sector, the company contributes to advancements in medical technology and diagnostic solutions. Based in Japan, Mizuho Medy is part of a broader network of companies innovating in healthcare solutions, underlining its market significance through reliability and the quality of its medical products. Its continuous efforts in research and development aim at enhancing efficacy and accessibility of medical diagnostics, ultimately impacting patient outcomes and healthcare efficiency.
“Mizuho Medy Co., Ltd.'s ROE is 19.0%. Explore profitability and growth together.”
Ask for details →Mizuho Medy Co., Ltd. (ticker: 4595) is a company listed on JPX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 187 employees.
The current price is 1,670 with a P/E ratio of -x and P/B of -x.
ROE is 19.01% and operating margin is 41.32%. Annual revenue is $11.3B.